Fluidigm Corporation,
the inventor of integrated fluidic circuits (IFCs), has appointed Química
Valaner S.A de C.V as exclusive distributor for Fluidigm's industry-leading
instrumentation and chips in Mexico. Fluidigm's IFCs, instrumentation
and software bring significant advantages to genetics researchers and scientists
performing real-time and digital PCR, genotyping, single-cell gene expression,
copy number variation and absolute quantification as well as sample prep for
next generation sequencing activities.
Fluidigm's systems utilize integrated fluidic circuits that contain a
microscopic matrix of microfluidic channels, valves and chambers on a rubber
chip that can perform thousands of experiments at a time, in a fully flexible
format that maximizes sensitivity, reduces costs and provides great reproducibility
of results.
“Fluidigm is committed to bringing the accuracy and efficiency benefits
of integrated fluidic circuit technology to life science researchers in Mexico,”
said Gajus Worthington, Fluidigm president and chief executive officer. “Química
Valaner has built a strong reputation of addressing the needs of life sciences
researchers. We are happy to have them represent Fluidigm in Mexico.”
“We are thrilled to partner with Fluidigm to bring integrated fluidic
circuit technology to our customers,” said Homero Hernandez, Química
Valaner president. “We hope to serve as the catalyst in bringing the benefits
of integrated fluidic circuit technology to Mexico's life science researchers.”
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic
Circuit (IFC) systems that significantly improve productivity in life science
research. Fluidigm's IFCs enable the simultaneous performance of thousands
of sophisticated biochemical measurements in extremely minute volumes. These
“integrated circuits for biology” are made possible by miniaturizing
and integrating liquid handling components on a single microfluidic device (IFC).
Fluidigm's systems, consisting of instrumentation, software and single-use
chips, increase throughput, decrease costs and enhance sensitivity compared
to conventional laboratory systems. Fluidigm products have not been cleared
or approved by the Food and Drug Administration for use as a diagnostic and
are only available for research use.